Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Short-term Investments: 2020-2025

Historic Short-term Investments for Ani Pharmaceuticals (ANIP) over the last 2 years, with Sep 2025 value amounting to $36,000.

  • Ani Pharmaceuticals' Short-term Investments rose 2.86% to $36,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $36,000, marking a year-over-year increase of 2.86%. This contributed to the annual value of $33,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Short-term Investments is $36,000, which was down 0.00% from $36,000 recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Short-term Investments high stood at $5.0 million for Q4 2022, and its period low was $33,000 during Q4 2024.
  • Its 2-year average for Short-term Investments is $34,800, with a median of $35,000 in 2024.
  • In the last 5 years, Ani Pharmaceuticals' Short-term Investments decreased by 0.04% in 2021 and then climbed by 2.86% in 2025.
  • Over the past 4 years, Ani Pharmaceuticals' Short-term Investments (Quarterly) stood at $5.0 million in 2021, then grew by 0.10% to $5.0 million in 2022, then reached $33,000 in 2024, then increased by 2.86% to $36,000 in 2025.
  • Its Short-term Investments was $36,000 in Q3 2025, compared to $36,000 in Q2 2025 and $34,000 in Q1 2025.